secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001093557-23-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom reports Q4 2022 preliminary revenue at least $815M (+17% YoY); FY2023 guidance $3.35-3.49B
--------------------------------------------------------------------------------

- Q4 2022 preliminary revenue at least $815M, up 17% YoY; U.S. $606M, international $209M.
- FY2022 preliminary revenue ~$2.91B, up 19% YoY on a reported basis.
- FY2023 revenue guidance $3.35B-$3.49B, representing 15-20% growth over 2022.
- FY2023 non-GAAP gross profit margin expected 62-63%; non-GAAP operating margin ~16.5%.
- CEO cites strong customer growth and G7 CGM regulatory clearances as key drivers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/0001093557-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000004/dxcm-20230109.htm
  HTML page:      https://secwatch.observer/filing/0001093557-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer